Purchase Order 15B50525P00000012
Award Date
10/1/24
Potential Completion Date
10/31/24
Potential Value
$22K
Federal Agency
Federal Medical Center Carswell
Awardee
Biologics, Inc.
Ultimate Awardee
Mckesson Corporation
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Cary, NC 27513, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $21,535.58 firm fixed price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical company, on January 10, 2025. The order is for the delivery of cancer drugs and biologics, with an ultimate completion date of January 10, 2025. Biologics, Inc. is a subsidiary of the larger McKesson Corporation, which is also a for-profit healthcare services and information technology company that holds various...
This is a $22,061.05 firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a for-profit pharmaceutical company and subsidiary of McKesson Corporation. The contract is for the delivery of cancer drugs and biologics to the federal agency during Fiscal Year 2025. The contract does not have a set-aside designation, indicating open competition. Biologics, Inc. is an established federal contractor that specializes in providing...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of the healthcare company McKesson Corporation. The $22,061.05 contract is for the delivery of cancer drugs and biologics, including medications such as TURALIO, CAPRELSA, LENALIDOMIDE, AYVAKIT, and XERMELO. The contract does not have a set-aside designation, indicating it was open to full and open competition. Biologics, Inc. has a history of...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in the amount of $22,061.05. The contract has an ultimate completion date of August 31, 2025. Biologics, Inc. is a for-profit pharmaceutical company that specializes in delivering critical medical treatments, particularly cancer medications, to various federal healthcare and...
This is a $22,061.05 firm fixed-price purchase order awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc., a subsidiary of McKesson Corporation, for the supply of cancer drugs and biologics in fiscal year 2025. The contract has no set-aside designation, indicating open competition. Biologics, Inc. is a pharmaceutical company focused on delivering critical medical treatments, particularly cancer medications, to various federal healthcare and correctional...
The federal contract award is for the purchase of TURALIO 125MG CANCER DRUG BIOLOGICS (BY MCKESSON) under a firm fixed-price purchase order. The $22,061.05 contract was awarded on December 1, 2024 to Biologics, Inc., a for-profit pharmaceutical provider, with Mckesson Corporation as the parent company. The ultimate completion date is January 31, 2025. The contract is being issued by the Federal Medical Center Carswell, a civilian agency, for delivery of the cancer treatment medication to the...
This is a firm fixed-price purchase order contract awarded by the Federal Medical Center Carswell, a civilian agency, to Biologics, Inc. to provide the cancer drug TURALIO 125MG. The order is for delivery during Fiscal Year 2025 with a completion date of February 18, 2025 and a ceiling value of $22,061.05. Biologics, Inc. is a for-profit organization that has previously held federal contracts to supply specialty pharmaceuticals to agencies such as the Department of Veterans Affairs and the...
This federal contract award is for the delivery of cancer medications to the Federal Correctional Complex Florence, a civilian agency under the Department of Justice. The prime contractor is Mckesson Corporation, a healthcare services and IT company that provides pharmaceuticals, medical supplies, and healthcare IT solutions to government agencies. The $43,318.43 firm fixed price delivery order was issued against an existing contract vehicle, with a period of performance through September...
This federal contract award was issued by the Federal Medical Center Carswell, a civilian agency, to the prime contractor Mckesson Corporation, doing business as Mckesson. The contract, valued at $71,844.42, is for the delivery of pharmaceutical drugs to the agency during fiscal year 2024. It is a firm fixed price delivery order contract with an ultimate completion date of August 1, 2024. No set-aside designations were used. Mckesson Corporation is a healthcare services and information...
This is a firm fixed price delivery order awarded by the Federal Medical Center Carswell, a civilian agency within the Department of Justice, to the prime contractor Mckesson Corporation. The $4,367,000.00 contract is for the provision of various medications during fiscal year 2016 and has an ultimate completion date of September 30, 2016. No set-aside designation was used. The award is associated with a larger indefinite delivery/indefinite quantity contract vehicle that Mckesson has used to...